Literature DB >> 32206052

COVID-19 and smoking: A systematic review of the evidence.

Constantine I Vardavas1,2, Katerina Nikitara2.   

Abstract

Entities:  

Keywords:  COVID-19; coronavirus; smoking; tobacco

Year:  2020        PMID: 32206052      PMCID: PMC7083240          DOI: 10.18332/tid/119324

Source DB:  PubMed          Journal:  Tob Induc Dis        ISSN: 1617-9625            Impact factor:   2.600


× No keyword cloud information.
Table 1

Overview of the five studies included in the systematic review

TitleSettingPopulationStudy design and time horizonOutcomesSmoking rates by outcome
Zhou et al.9 (2020)Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyJinyintan Hospital and Wuhan Pulmonary Hospital, Wuhan, ChinaAll adult inpatients (aged ≥18 years) with laboratory confirmed COVID-19 (191 patients)Retrospective multicenter cohort study until 31 January 2020Mortality54 patients died during hospitalisation and 137 were dischargedCurrent smokers: n=11 (6%)Non-survivors: n=5 (9%)Survivors: n=6 (4%)(p=0.20)Current smoker vs non-smokerUnivariate logistic regression(OR=2.23; 95% CI: 0.65–7.63; p=0.2)
Zhang et al.10(2020)Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, ChinaNo. 7 Hospital of Wuhan, ChinaAll hospitalised patients clinically diagnosed as ‘viral pneumonia’ based on their clinical symptoms with typical changes in chest radiology (140 patients)Retrospective 16 January to 3 February 2020Disease SeverityNon-severepatients: n=82Severe patients:n=58Disease SeverityFormer smokers: n=7Severe: n=4 (6.9%)Non-severe: n=3 (3.7%) (p= 0.448)Current smokers: n=2Severe: n=2 (3.4%)Non-severe: n=0 (0%)
Guan et al.12(2019)Clinical Characteristics of Coronavirus Disease 2019 in China552 hospitals in 30 provinces, autonomous regions, and municipalities in mainland ChinaPatients with laboratory-confirmed COVID-19 (1099 patients)Retrospective until 29 January 2020Severity and admission to an ICU, the use of mechanical ventilation, or deathNon-severe patients: n=926 Severe patients: n=173By severitySevere cases16.9% current smokers5.2% former smokers77.9% never smokersNon-severe cases11.8% current smokers1.3% former smokers86.9% never smokersBy mechanical ventilation, ICU or deathNeeded mechanical ventilation, ICU or died25.8% current smokers7.6% former smokers66.7% non-smokersNo mechanical ventilation, ICU or death11.8% current smokers1.6% former smokers86.7% never smokers
Huang et al.11(2020)Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaA hospital in Wuhan, ChinaLaboratory-confirmed 2019-nCoV patients in Wuhan (41 patients)Prospective from 16 December 2019 to 2 January 2020MortalityAs of 22 January 2020, 28 (68%) of 41 patients were discharged and 6 (15%) patients diedCurrent smokers: n=3ICU care: n=0Non-ICU care: n=3 (11%)Current smokers in ICU care vs non-ICU care patients (p=0.31)
Liu et al.13 (2019)Analysis of factors associated with disease outcomes in hospitalised patients with 2019 novel coronavirus diseaseThree tertiary hospitals in Wuhan, ChinaPatients tested positive for COVID-19 (78 patients)Retrospective multicentre cohort study from 30 December 2019 to 15 January 2020Disease progression11 patients (14.1%) in the progression group 67 patients (85.9%) in the improvement/stabilization group 2 deathsNegative progression group: 27.3% smokersIn the improvement group: 3% smokersThe negative progression group had a significantly higher proportion of patients with a history of smoking than the improvement/stabilisation group (27.3% vs 3.0%)Multivariate logistic regression analysis indicated that the history of smoking was a risk factor of disease progression (OR=14.28; 95% CI: 1.58–25.00; p= 0.018)
  12 in total

1.  Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.

Authors:  Jin-Jin Zhang; Xiang Dong; Yi-Yuan Cao; Ya-Dong Yuan; Yi-Bin Yang; You-Qin Yan; Cezmi A Akdis; Ya-Dong Gao
Journal:  Allergy       Date:  2020-02-27       Impact factor: 13.146

2.  The 2019 Novel Coronavirus Outbreak - A Global Threat.

Authors:  Wasim Yunus Khot; Milind Y Nadkar
Journal:  J Assoc Physicians India       Date:  2020-03

Review 3.  Cigarette smoking and infection.

Authors:  Lidia Arcavi; Neal L Benowitz
Journal:  Arch Intern Med       Date:  2004-11-08

Review 4.  Are healthy smokers really healthy?

Authors:  Zijing Zhou; Ping Chen; Hong Peng
Journal:  Tob Induc Dis       Date:  2016-11-15       Impact factor: 2.600

5.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

6.  Secular trends in smoking in relation to prevalent and incident smoking-related disease: A prospective population-based study.

Authors:  Philip Tonnesen; Jacob L Marott; Børge Nordestgaard; Stig Egil Bojesen; Peter Lange
Journal:  Tob Induc Dis       Date:  2019-10-07       Impact factor: 2.600

7.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.

Authors:  Qun Li; Xuhua Guan; Peng Wu; Xiaoye Wang; Lei Zhou; Yeqing Tong; Ruiqi Ren; Kathy S M Leung; Eric H Y Lau; Jessica Y Wong; Xuesen Xing; Nijuan Xiang; Yang Wu; Chao Li; Qi Chen; Dan Li; Tian Liu; Jing Zhao; Man Liu; Wenxiao Tu; Chuding Chen; Lianmei Jin; Rui Yang; Qi Wang; Suhua Zhou; Rui Wang; Hui Liu; Yinbo Luo; Yuan Liu; Ge Shao; Huan Li; Zhongfa Tao; Yang Yang; Zhiqiang Deng; Boxi Liu; Zhitao Ma; Yanping Zhang; Guoqing Shi; Tommy T Y Lam; Joseph T Wu; George F Gao; Benjamin J Cowling; Bo Yang; Gabriel M Leung; Zijian Feng
Journal:  N Engl J Med       Date:  2020-01-29       Impact factor: 176.079

8.  Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study.

Authors:  Joseph T Wu; Kathy Leung; Gabriel M Leung
Journal:  Lancet       Date:  2020-01-31       Impact factor: 79.321

9.  Clinical Characteristics of Coronavirus Disease 2019 in China.

Authors:  Wei-Jie Guan; Zheng-Yi Ni; Yu Hu; Wen-Hua Liang; Chun-Quan Ou; Jian-Xing He; Lei Liu; Hong Shan; Chun-Liang Lei; David S C Hui; Bin Du; Lan-Juan Li; Guang Zeng; Kwok-Yung Yuen; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Ping-Yan Chen; Jie Xiang; Shi-Yue Li; Jin-Lin Wang; Zi-Jing Liang; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Nan-Shan Zhong
Journal:  N Engl J Med       Date:  2020-02-28       Impact factor: 91.245

10.  Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease.

Authors:  Wei Liu; Zhao-Wu Tao; Lei Wang; Ming-Li Yuan; Kui Liu; Ling Zhou; Shuang Wei; Yan Deng; Jing Liu; Hui-Guo Liu; Ming Yang; Yi Hu
Journal:  Chin Med J (Engl)       Date:  2020-05-05       Impact factor: 2.628

View more
  380 in total

1.  Look at the wood and not at the tree: The Microbiome in Chronic Obstructive Lung Disease and Cystic Fibrosis.

Authors:  Eduard Monsó
Journal:  Arch Bronconeumol (Engl Ed)       Date:  2019-06-01       Impact factor: 4.872

2.  Vape shop and consumer activity during COVID-19 non-essential business closures in the USA.

Authors:  Carla J Berg; Rachel Callanan; Trent O Johnson; Nina C Schliecher; Steve Sussman; Theodore L Wagener; Mark Meaney; Lisa Henriksen
Journal:  Tob Control       Date:  2020-10-19       Impact factor: 7.552

3.  COVID-19 and Tobacco.

Authors:  Carlos Rábade Castedo; Jaime Signes-Costa; Carlos A Jiménez-Ruiz
Journal:  Arch Bronconeumol       Date:  2020-08-21       Impact factor: 4.872

4.  COVID-19 and Smoking: A Systematic Review and Meta-Analysis of the Evidence.

Authors:  Carlos A Jiménez-Ruiz; Daniel López-Padilla; Adolfo Alonso-Arroyo; Rafael Aleixandre-Benavent; Segismundo Solano-Reina; José Ignacio de Granda-Orive
Journal:  Arch Bronconeumol       Date:  2020-07-25       Impact factor: 4.872

5.  Sex and Gender Differences in Lung Disease.

Authors:  Patricia Silveyra; Nathalie Fuentes; Daniel Enrique Rodriguez Bauza
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Pharmacotherapy Impacts on COPD Mortality.

Authors:  Bartolome Celli; Miguel Divo; Victor Pinto Plata
Journal:  Arch Bronconeumol (Engl Ed)       Date:  2020-05-21       Impact factor: 4.872

7.  Lockdown exit strategies and risk of a second epidemic peak: a stochastic agent-based model of SARS-CoV-2 epidemic in France.

Authors:  Nicolas Hoertel; Martin Blachier; Carlos Blanco; Mark Olfson; Marc Massetti; Marina Sánchez Rico; Frédéric Limosin; Henri Leleu
Journal:  medRxiv       Date:  2020-05-05

Review 8.  Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature.

Authors:  Prasad Katulanda; Harsha A Dissanayake; Ishara Ranathunga; Vithiya Ratnasamy; Piyumi S A Wijewickrama; Nilukshana Yogendranathan; Kavinga K K Gamage; Nipun L de Silva; Manilka Sumanatilleke; Noel P Somasundaram; David R Matthews
Journal:  Diabetologia       Date:  2020-05-14       Impact factor: 10.122

Review 9.  The Role of Smoking and Nicotine in the Transmission and Pathogenesis of COVID-19.

Authors:  Ali Ehsan Sifat; Saeideh Nozohouri; Heidi Villalba; Bhuvaneshwar Vaidya; Thomas J Abbruscato
Journal:  J Pharmacol Exp Ther       Date:  2020-10-08       Impact factor: 4.030

10.  Gender, age and comorbidities as the main prognostic factors in patients with COVID-19 pneumonia.

Authors:  Jun Mi; Weimin Zhong; Chaoqun Huang; Wanwan Zhang; Li Tan; Lili Ding
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.